Evidence map›Paper›PMID 40986124›Full record

ReviewCancer metastasis reviews2025

The Bermuda Triangle of paediatric brain cancers: epigenetics, developmental timing window and cell of origin.

Afraah Cassim, Yolanda Colino-Sanguino, Sarah L Fox, Laura Rodriguez de la Fuente, Hannah E Hartley, Fatima Valdes-Mora

Abstract readReview
In one paragraph

Review in Cancer metastasis reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. On the origins of childhood cancer.Cancer metastasis reviews · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Afraah CassimCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.
Yolanda Colino-SanguinoCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.
Sarah L FoxCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.
Laura Rodriguez de la FuenteCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.
Hannah E HartleyCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.
Fatima Valdes-MoraCancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia. fvaldesmora@ccia.org.au.

Funding

Cure Brain Cancer fellowship 20210917National Health and Medical Research Council 2023/GNT2029912
6 · The paper itself

Abstract

Paediatric brain cancers are aggressive tumours that urgently need deeper understanding of their cellular and molecular vulnerabilities to facilitate the development of effective treatments. These tumours frequently arise from epigenetic alterations in specific immature cell states of the developing prenatal or neonatal brain. In this review, we propose a "three-event" model composed of an epigenetic event, developmental timing window and the cell of origin for tumour initiation in paediatric brain tumours. We focus on three types of paediatric gliomas: diffuse midline gliomas (DMG), diffuse hemispheric gliomas (DHG) and posterior fossa A ependymomas (PFA-EPN), which reflect our proposed three-event model. Additionally, we discuss the methods and models used to study these three events separately or simultaneously. Taken together, this review highlights the spatio-temporal vulnerable cell states during brain development and which molecular drivers hijack these cues to induce cell state stalling and tumour initiation. The next steps to expand our understanding of the order of events and their use in therapy are further discussed.

Indexed as

Brain NeoplasmsEpigenesis, GeneticGliomaAnimalsChildHumansBrain developmentCell of originDiffuse high-grade gliomasEpendymomasEpigeneticsPaediatric brain cancer

Identifiers

PMID40986124
PMCPMC12457541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.